Speaker illustration

Doctor Akihiro Nakamura

Iwate Prefectural Central Hospital, Morioka (Japan)

Effects of evolocumab on plasma levels of proprotein convertase subtilisin/kexin type 9 and lipoprotein(a) in acute myocardial infarction

Event: ESC CONGRESS 2020 - The Digital Experience

Topic: Lipid-Lowering Agents

Session: Pharmacology and Pharmacotherapy ePosters

Thumbnail

This platform is supported by

logo Novo Nordisk